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Background Anti-apoptotic signals induced downstream of HER2 are known to
contribute to the resistance to current treatments of breast cancer cells that
overexpress this member of the EGFR family. Whether or not some of these signals
are also involved in tumor maintenance by counteracting constitutive death signals is
much less understood. To address this, we investigated what role anti- and pro-
apoptotic Bcl-2 family members, key regulators of cancer cell survival, might play in
the viability of HER2 overexpressing breast cancer cells. Methods We used cell lines
as an in vitro model of HER2-overexpressing cells in order to evaluate how anti-
apoptotic Bcl-2, Bcl-xL and Mcl-1, and pro-apoptotic Puma and Bim impact on their
survival, and to investigate how the constitutive expression of these proteins is
regulated. Expression of the proteins of interest was confirmed using lysates from
HER2-overexpressing tumors and through analysis of publicly available RNA
expression data. Results We show that the depletion of Mcl-1 is sufficient to induce
apoptosis in HER2-overexpressing breast cancer cells. This Mcl-1 dependence is due
to Bim expression and it directly results from oncogenic signaling, as depletion of the
oncoprotein c-Myc, which occupies regions of the Bim promoter as evaluated in ChIP
assays, decreases Bim levels and mitigates Mcl-1 dependence. Consistently, a
reduction of c-Myc expression by inhibition of mTORC1 activity abrogates occupancy
of the Bim promoter by c-Myc, decreases Bim expression and promotes tolerance to
Mcl-1 depletion. Western blot analysis confirms that naïve HER2-overexpressing
tumors constitutively express detectable levels of Mcl-1 and Bim, while expression
data hint on enrichment for Mcl-1 transcripts in these tumors. Conclusions This work
establishes that, in HER2-overexpressing tumors, it is necessary, and maybe
sufficient, to therapeutically impact on the Mcl-1/Bim balance for efficient induction
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